Passage BIO PASG
NASDAQ PASG
$4.00 +0.22 (+5.82%)
At close: Nov 11, 2026 · 4:00 PM EST

Passage BIO (PASG) Other financing activities (as filed) (2019 - 2021)

Updated

Passage BIO (PASG) posted Other financing activities of $763,000 for FY2019.

Analysis

Passage BIO (PASG) Other financing activities (as filed) (2019 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Passage BIO 12.16 Mn -111.84 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 -86,000.00
Mar 31, 2021 -252,000.00
Dec 31, 2019 -743,000.00
Sep 30, 2019 -15,000.00
API Access

Passage BIO Other financing activities (as filed) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=PASG&period=max&api_key=YOUR_API_KEY